Search results :

Dabrafenib

More information: STITCH, PubChem and possibly Wikipedia

ATC Codes: None found

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3
Lymphopenia 6% - 59% x
Gamma-glutamyltransferase increased 2% - 56% x
Decreased appetite very common, 0% - 30% x x x
Hypophosphataemia common, 0% - 47% x x x
Hypoalbuminaemia 0% - 53% x
Hypokalaemia 2% - 29% x
Phosphatase alkaline increased 0% - 67% x x
Aspartate aminotransferase increased 0% - 60% x
Hyperkalaemia 0% - 22% x
Chills very common, 0% - 58% x x x
Body temperature increased very common, 0% - 71% x x x
Oedema peripheral 0% - 31% x
Alanine aminotransferase increased 0% - 42% x
Creatinine increased 0% - 24% x
Neutropenia 0% - 55% x x
Hyperglycaemia common, 0% - 67% x x x
Nausea very common, 0% - 50.8% x x x
Thrombocytopenia 0% - 31% x
Hyponatraemia 0% - 55% x x
Pruritus 0% - 13% x x
Bowen's disease common x
Basal cell carcinoma common x x
Fatigue very common, 0% - 57% x x x
Keratoacanthoma common x x x
Actinic keratosis common, 0% - 15% x x x
Seborrhoeic keratosis common x x
Skin lesion common x x
Acrochordon common x x
Dry skin common, 0% - 18% x x x
Influenza like illness common x x
Squamous cell carcinoma of skin common x x x
Insomnia 0% - 18% x
Dizziness 0% - 16% x
Hypocalcaemia 0% - 20% x
Back pain 0% - 18% x x
Urinary tract infection 0% - 13% x
Vomiting very common, 0% - 43% x x x
Anaemia 0% - 55% x x
Leukopenia 0% - 62% x x
Haemorrhage 0% - 16% x
Hypercalcaemia 0% - 19% x
Night sweats 0% - 24% x
Dry mouth 0% - 11% x
Abdominal pain 0% - 33% x x x
Constipation common, 0% - 22% x x x
Dehydration 0% - 11% x x
Diarrhoea very common, 0% - 36% x x x
Headache very common, 0% - 37% x x x
Hyperbilirubinaemia 0% - 15% x
Pain in extremity very common, 0% - 19% x x x
Erythema common, 0% - 15% x x x
Hypomagnesaemia 0% - 18% x
Dermatitis acneiform 0% - 16% x
Alopecia very common, 0% - 22% x x x
Asthenia very common, 0% - 17.6% x x x
Arthralgia very common, 0% - 44% x x x
Papilloma 0% - 27% x x x
Muscle spasms 0% - 16% x
Hypersensitivity uncommon x x x
Renal failure acute uncommon x x x
Malignant melanoma uncommon x
Nephritis uncommon x x
Pancreatitis uncommon x x x
Panniculitis uncommon x x
Renal failure uncommon, 0% - 7% x x x
Uveitis uncommon x x
Hyperkeratosis very common, 0% - 37% x x x
Arrhythmia x
Mental disorder x
Bone disorder x
Neoplasm malignant x x
Squamous cell carcinoma x x
Cellulitis x
Infection x
Connective tissue disorder x x x
Cough very common, 0% - 29% x x x
Cyst x x x
Oedema x
Epistaxis x
Rash very common, 0% - 53% x x x
Eye disorder x x x
Eye haemorrhage x
Folliculitis x
Gastrointestinal disorder x x x
Gingival bleeding x
Cardiac failure congestive x
Haematuria x
Hyperhidrosis x
Hypertension x
Hypotension x
Immune system disorder x x x
Nephropathy x
Lymphoedema x
Mediastinal disorder x x x
Nasopharyngitis 0% - 10.2% x x
Neoplasm x x x
Nephritis interstitial x
Nervous system disorder x x x
Paronychia x
Polyp x x x
Prurigo x
Stomatitis x
Urinary tract disorder x x
Angiopathy x
Vitreous haemorrhage x
Rash pustular x
Haemorrhage intracranial x
Blindness transient x
Malnutrition x x x
Unspecified disorder of skin and subcutaneous tissue x x x
Rash macular x
Rash vesicular x
Myalgia very common, 0% - 24% x x x
Abdominal discomfort x
Abdominal pain upper x
Abdominal pain lower x
Rash erythematous x
Gastric haemorrhage x
Reaction febrile x
Rash bullous x
Azotaemia x
Disease progression x
Vision blurred x
Skin papilloma 0% - 24.1% x x
Rash maculo-papular x
Rigors x
Rash generalised x
Brain stem haemorrhage x
Ejection fraction decreased x
Infestation NOS x
Electrocardiogram QT corrected interval prolonged x
Refractory hypertension x
Cardiomyopathy x
Skin toxicity x
Ocular toxicity x
Rash papular x
Acute renal insufficiency x
Venous thromboembolism x
Oropharyngeal pain 0% - 13% x
Cerebral haemorrhage x
Vaginal haemorrhage x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

dabrafenib / dabrafenib

Side effects:59
Source:EMA

Dabrafenib mesilate / TAFINLAR CAPSULES

Side effects:60
Source:medicines.org.au

DABRAFENIB

Side effects:125
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label